Discovery of a first-in-class orally available HBV cccDNA inhibitor.
J Hepatol
; 78(4): 742-753, 2023 04.
Article
in En
| MEDLINE
| ID: mdl-36587899
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Hepatitis B, Chronic
Limits:
Animals
/
Humans
Language:
En
Journal:
J Hepatol
Journal subject:
GASTROENTEROLOGIA
Year:
2023
Document type:
Article
Country of publication:
Netherlands